These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21279958)

  • 1. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors.
    Afify AM; Tate S; Durbin-Johnson B; Rocke DM; Konia T
    Int J Biol Markers; 2011; 26(1):50-7. PubMed ID: 21279958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H; Fang J; Du G
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep; 21(9):541-3. PubMed ID: 11360506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and significance of CD44s, CD44v6, and nm23 mRNA in human cancer.
    Liu YJ; Yan PS; Li J; Jia JF
    World J Gastroenterol; 2005 Nov; 11(42):6601-6. PubMed ID: 16425351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant expression of CD44 in preneoplastic lesions of the lung.
    Wimmel A; Kogan E; Ramaswamy A; Schuermann M
    Cancer; 2001 Sep; 92(5):1231-6. PubMed ID: 11571737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
    Tran TA; Kallakury BV; Sheehan CE; Ross JS
    Hum Pathol; 1997 Jul; 28(7):809-14. PubMed ID: 9224749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 and its v6 spliced variant in lung tumors: a role in histogenesis?
    Fasano M; Sabatini MT; Wieczorek R; Sidhu G; Goswami S; Jagirdar J
    Cancer; 1997 Jul; 80(1):34-41. PubMed ID: 9210706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas.
    Berner HS; Suo Z; Risberg B; Villman K; Karlsson MG; Nesland JM
    Histopathology; 2003 Jun; 42(6):546-54. PubMed ID: 12786890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD44 and its clinical implication in diffuse-type and intestinal-type gastric adenocarcinomas.
    Hong RL; Lee WJ; Shun CT; Chu JS; Chen YC
    Oncology; 1995; 52(4):334-9. PubMed ID: 7539903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression tumor stem cell surface marker CD44 in gastric cancer and its significance].
    Xie JW; Huang CM; Zheng CH; Li P; Wang JB; Lin JX; Lu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1107-12. PubMed ID: 24277411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA; van Steenbrugge GJ; Verkaik NS; Schröder FH; van der Kwast TH
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD44 and variant proteins in human colorectal cancer and its relevance for prognosis.
    Ropponen KM; Eskelinen MJ; Lipponen PK; Alhava E; Kosma VM
    Scand J Gastroenterol; 1998 Mar; 33(3):301-9. PubMed ID: 9548625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer.
    Omran OM; Ata HS
    Ultrastruct Pathol; 2012 May; 36(3):145-52. PubMed ID: 22559040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S; He JL; Qiu ZX; Chen NY; Luo Z; Chen BJ; Li WM
    Asian Pac J Cancer Prev; 2014; 15(16):6761-6. PubMed ID: 25169522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis.
    Jiang H; Zhao W; Shao W
    Tumour Biol; 2014 Aug; 35(8):7383-9. PubMed ID: 24913707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers, but not in small cell lung cancers.
    Kondo K; Miyoshi T; Hino N; Shimizu E; Masuda N; Takada M; Uyama T; Monden Y
    J Surg Oncol; 1998 Nov; 69(3):128-36. PubMed ID: 9846498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
    Hirata T; Fukuse T; Naiki H; Hitomi S; Wada H
    Cancer Res; 1998 Mar; 58(6):1108-10. PubMed ID: 9515789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of CD44v6 in metastases of intestinal and diffuse types of gastric carcinoma.
    Castellà EM; Ariza A; Pellicer I; Fernández-Vasalo A; Ojanguren I
    J Clin Pathol; 1998 Feb; 51(2):134-7. PubMed ID: 9602687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.